Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: H2RA
Active Ingredient: Ranitidine hydrochloride 168mg equivalent to ranitidine 150mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Arrow Pharmaceuticals Inc, Mississauga, Ontario, Canada
Product: Lisinopril
Active Ingredient: Lisinopril dihydrate 10.89mg equivalent to lisinopril 10mg
Dosage Form: Tablet
New Zealand Sponsor: IPCA Pharma (NZ) Pty Limited
Manufacturer: IPCA Laboratories Limited, Athal, Silvassa, Dadra and Nagar Haveli (U T), India
Product: Lisinopril
Active Ingredient: Lisinopril dihydrate 2.723mg equivalent to lisinopril 2.5mg
Dosage Form: Tablet
New Zealand Sponsor: IPCA Pharma (NZ) Pty Limited
Manufacturer: IPCA Laboratories Limited, Athal, Silvassa, Dadra and Nagar Haveli (U T), India
Product: Lisinopril
Active Ingredient: Lisinopril dihydrate 21.78mg equivalent to lisinopril 20mg
Dosage Form: Tablet
New Zealand Sponsor: IPCA Pharma (NZ) Pty Limited
Manufacturer: IPCA Laboratories Limited, Athal, Silvassa, Dadra and Nagar Haveli (U T), India
Product: Lisinopril
Active Ingredient: Lisinopril dihydrate 5.445mg equivalent to lisinopril 5mg
Dosage Form: Tablet
New Zealand Sponsor: IPCA Pharma (NZ) Pty Limited
Manufacturer: IPCA Laboratories Limited, Athal, Silvassa, Dadra and Nagar Haveli (U T), India
Product: Lisoril
Active Ingredient: Lisinopril dihydrate 10.89mg equivalent to lisinopril 10mg
Dosage Form: Tablet
New Zealand Sponsor: IPCA Pharma (NZ) Pty Limited
Manufacturer: IPCA Laboratories Limited, Athal, Silvassa, Dadra and Nagar Haveli (U T), India
Product: Lisoril
Active Ingredient: Lisinopril dihydrate 2.723mg equivalent to lisinopril 2.5mg
Dosage Form: Tablet
New Zealand Sponsor: IPCA Pharma (NZ) Pty Limited
Manufacturer: IPCA Laboratories Limited, Athal, Silvassa, Dadra and Nagar Haveli (U T), India
Product: Lisoril
Active Ingredient: Lisinopril dihydrate 21.78mg equivalent to lisinopril 20mg
Dosage Form: Tablet
New Zealand Sponsor: IPCA Pharma (NZ) Pty Limited
Manufacturer: IPCA Laboratories Limited, Athal, Silvassa, Dadra and Nagar Haveli (U T), India
Product: Lisoril
Active Ingredient: Lisinopril dihydrate 5.445mg equivalent to lisinopril 5mg
Dosage Form: Tablet
New Zealand Sponsor: IPCA Pharma (NZ) Pty Limited
Manufacturer: IPCA Laboratories Limited, Athal, Silvassa, Dadra and Nagar Haveli (U T), India
Dated this 7th day of September 2007.
ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).